Inhibikase Therapeutics, Inc. - Common Stock (IKT)

2.3900
+0.0400 (1.70%)
NASDAQ· Last Trade: Aug 21st, 7:38 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors